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Abstract
Background: Cardiac output (CO) is an important determinant of the hemodynamic
state in patients with congestive heart failure (CHF). We tested the hypothesis that
CO can be estimated from the right ventricular (RV) pressure waveform in CHF
patients using a pulse contour cardiac output algorithm that considers constant but
patient specific RV outflow tract characteristic impedance.
Method: In 12 patients with CHF, breath-by-breath Fick CO and RV pressure
waveforms were recorded utilizing an implantable hemodynamic monitor during a
bicycle exercise protocol. These data were analyzed retrospectively to assess changes
in characteristic impedance of the RV outflow tract during exercise. Four patients
that were implanted with an implantable cardiac defibrillator (ICD) implementing the
algorithm were studied prospectively. During a two staged sub-maximal bicycle
exercise test conducted at 4 and 16 weeks of implant, COs measured by direct Fick
technique and estimated by the ICD were recorded and compared.
Results: At rest the total pulmonary arterial resistance and the characteristic
impedance were 675 ± 345 and 48 ± 18 dyn.s.cm
-5, respectively. During sub-maximal
exercise, the total pulmonary arterial resistance decreased (Δ 91 ± 159 dyn.s.cm
-5,
p < 0.05) but the characteristic impedance was unaffected (Δ 3 ± 9 dyn.s.cm
-5, NS).
The algorithm derived cardiac output estimates correlated with Fick CO (7.6 ± 2.5 L/min,
R
2 = 0.92) with a limit of agreement of 1.7 L/min and tracked changes in Fick CO
(R
2 = 0.73).
Conclusions: The analysis of right ventricular pressure waveforms continuously
recorded by an implantable hemodynamic monitor provides an estimate of CO and
may prove useful in guiding treatment in patients with CHF.
Keywords: Ventricle Pressure, Cardiac Output, Exercise, Pulmonary Artery
Introduction
Cardiac output (CO), together with measures of cardiac filling pressures and peripheral
resistance, is a key variable to describe hemodynamic pathophysiology in patients with
heart failure. At rest, heart failure patients often maintain a normal CO until later
stages of the disease, when CO becomes too low to meet the metabolic demands of
the body [1]. However, CO measurements during exercise reveal important informa-
tion about the severity and prognosis of the disease [2,3] in patients with milder forms
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reproduction in any medium, provided the original work is properly cited.of congestive heart failure (CHF). Standard diagnostic tools to determine CO are com-
monly bound to the artificial laboratory environment and only provide situational
information. Furthermore, the accurate assessment of CO usually requires invasive
procedures that are associated with risks a n dc o s t s .T h e r e f o r e ,c o n t i n u o u sC Om o n i -
toring from an implanted sensor may overcome these obstacles and provide useful
information to improve the management of patients with CHF.
CO can be affected by disorders that affect both left and right ventricular (RV) func-
tion [4,5]. CHF patients with elevated RV afterload have poor prognosis with a hazard
ratio almost four times that of patients with normal RV afterload [5]. The true RV
afterload, however, is not sufficiently reflected by simple mean pulmonary arterial pres-
sure but is rather determined by a complex interaction of both steady (total pulmonary
resistance) and oscillatory components (characteristic impedance and pressure wave
reflection) [6] both of which are abnormal in CHF patients [7] at rest and during exer-
cise [4].
Recently, continuous monitoring of right ventricular pressure parameters, recorded
either from an implantable hemodynamic monitor (IHM) [8] or using a sensor incor-
porated in an implantable defibrillator [9], has been proposed to provide reliable long-
term information on cardiac filling pressures in CHF patients. Using similar sensor
technology, we have described a method to estimate CO from high fidelity RV pressure
waveforms in an open chest canine model [10] and in humans with pulmonary arterial
hypertension [11]. This algorithm assumes that the characteristic impedance of the RV
outflow tract remains constant for a given individual [10] and accommodates the pre-
sence of pressure wave reflection [11].
The present study aims to investigate if this assumption remains valid in exercising
heart failure patients and to assess if this algorithm can also be used to derive esti-
mates of CO for continuous measurements in patients with heart failure who are
implanted with an IHM or an ICD with pressure monitoring capabilities. For this pur-
pose, retrospective hemodynamic data obtained during stationary bike tests were
pooled with data from prospective chronic studies in patients implanted with an ICD
implementing the algorithm to further validate these assumptions and to assess the
bias and agreement of this method to the Fick method.
Materials and methods
Patient population and inclusion/exclusion criteria
Hemodynamic data from six male patients who were enrolled in a pilot trial [12]
(Group I) and six male patients who were enrolled in the Chronicle
® Phase I technical
feasibility study [13] (Group II) were retrospectively analyzed. Four male patients were
then studied prospectively (Group III). In all groups, patients were included if they had
chronic heart failure for >3 months in duration and were in NYHA-class II or III.
Patients were excluded if they had any known uncorrected congenital heart disease, tri-
cuspid or pulmonary valve stenosis, a mechanical right heart valve prosthesis, a pre-
viously implanted device in which transvenous leads remained in the heart, a terminal
illness unrelated to their heart failure with life expectancy less than one year, were
expected to undergo heart transplantation within 12 months or if they were unable to
give consent. The institutional ethics committee approved the study and written,
informed consent was obtained from each patient prior to enrollment.
Karamanoglu et al. BioMedical Engineering OnLine 2011, 10:36
http://www.biomedical-engineering-online.com/content/10/1/36
Page 2 of 13Study protocol
Patients in Group I and II received an IHM system (Chronicle
®, Medtronic, Inc. Min-
neapolis, USA) which was implanted in the left subclavicular region using standard
techniques for pacemaker insertion [14]. The RV lead, equipped with a pressure sensor
was inserted via the subclavian vein or the internal jugular vein. The tip of the lead
was positioned in the RV outflow tract and the pressure sensor was three centimeters
proximal to the tip. Group III patients, implanted with a combined ICD and hemody-
namic monitoring device implementing the algorithm for CO analysis (Chronicle-ICD,
Medtronic, Inc. Minneapolis, USA) also received a standard bipolar defibrillation lead
in the right ventricle [9].
Group I patients were studied at the time of the implant and performed submaximal
bicycle exercise on an ergometer in supine position (6 minutes at 30 watts). Group II
patients were studied at least one month after the implant and performed a two-staged
upright bicycle exercise protocol (6 minutes at 25 watts followed by 3 minutes at 50
watts). Group III patients were studied at one and four months after implant at rest in
supine position, standing and during upright bicycle exercise at 50 and 70% of the
maximal work load. The maximal workload was determined during an exercise test
one week before the one month test.
During exercise, pulmonary artery (PA) pressure, and mixed venous oxygen satura-
tion were measured by an oximetric probe (Opticath, Oximetrix, Abbott Lab, Chicago,
IL, USA). The ventricular pressure waveforms and arterial oxygen saturation were
recorded by the IHM and by finger probe oximetry, respectively.
Oxygen consumption was measured breath-by-breath, using a metabolic assessment
system (Groups I and II: CPX, Medgraphics, St Paul, MN, USA; Group III: Innocor,
Innovision, Odense S, Denmark). For Groups I and II, breath-by-breath CO was calcu-
lated according to the Fick principle, using mixed venous oxygen saturation from the
optical catheter, arterial oxygen saturation from the finger probe oximeter and oxygen
consumption. For Group III, CO was calculated at the end of each intervention
according to the Fick principle, using arterial and mixed venous blood samples and
oxygen consumption. Beat-by-beat RV pressure waveforms, RV pressure derived esti-
mated cardiac output (Group III) and breath-by-breath oxygen consumption values
were saved to a computer disk for subsequent analysis.
PCCO Algorithm
A beat-by-beat estimate of the CO was calculated using a previously established RV
pressure waveform based pulse contour CO algorithm, PCCO [10,11]. This algorithm
relies on the principle that the RV outflow contour can be identified in the RV pres-
sure waveform using first and higher order pressure waveform derivatives [10, 11, 15-
19, Figure 1). The algorithm provides an estimate of the cardiac output, eCO, as:
eCO(L/min) = HRx
(P1st − PES)xED
2
×
1
Zc
(1)
where the ejection duration (ED) corresponds to the time interval between dP/dtmax and
dP/dtmin. We have previously shown that the small error (<2%) introduced by triangular
approximation of the outflow waveform can be ignored [10]. The P1st and PES denote
pressures at the time of peak flow and at the dP/dtmin, respectively. The coefficient Zc is
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by changes in pressure or flows. Note that if the value of Zc is unknown but assumed to
be constant, Equation 1 denotes the cardiac output normalized to Zc, [10,11]. The value of
Zc can easily be calculated empirically as the ratio of cardiac output (measured using a
gold standard method) to first two terms of the Equation 1.
In Groups I and II, Equation 1 was implemented in dedicated software which was
used to analyze the recorded RV pressure waveforms on a personal computer. In
Group III, the PCCO algorithm was implemented in the hardware of the ICD which
had the capability of recording the RV pressure waveform. Using this algorithm, beat-
by-beat eCO values were calculated (Zc was assumed to be unknown) and stored in
the ICD memory to allow measurements in chronic ambulatory settings. Using custom
software, these stored eCO data were subsequently retrieved and analyzed.
Figure 1 A schematic illustration of the basic features of the RV pressure waveform (Top) and the
identification of these feature points using the first derivative, dP/dt, of the RV pressure waveform
(Middle). Three of these points identify the turning points of the RV outflow waveform approximated as a
triangle (Bottom). The vertices of the flow waveform correspond to time of dP/dtmax, peak flow (Qmax )=
time to early systolic shoulder of the RV pressure waveform (P1st), the time of dP/dtmin. Hence, the triangle
inscribed in the RV pressure waveform corresponds to the approximated RV outflow waveform. The
ejection duration (ED) is defined as the difference between time of dP/dtmax and time of dP/dtmin,P es is
the pressure at the time of dP/dtmin. The RV diastolic pressure (RVDP) is measured at the time of the R-
wave from the electrogram (EGM).
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Baseline and exercise values of steady and oscillator components of the RV afterload
were calculated to assess differences between patients and influence of exercise. In par-
ticular, the changes in characteristic impedance due to exercise was calculated to verify
the assumptions of the algorithm. Both the IHM and the ICD can analyze the RV pres-
sure waveform on a beat-by-beat basis, extract and store the values of right ventricular
diastolic pressure (RVDP), right ventricular systolic pressure (RVSP) and the estimated
mean PA pressure (eMPAP) [12-15,20]. Using these hemodynamic parameters, the
eCO and the directly measured cardiac output (mCO), the outflow tract characteris-
tic impedance,Z c, was computed as the ratio of eCO to mCO and the pulmonary
arterial resistance (PAR) was calculated as the ratio of eMPAP to mCO. Once PAR
and the Zc, were known, the coefficient of wave reflection, Γ, was calculated as [6,15]:
  =
PAR − Zc
PAR + Zc
(2)
Data Analysis and Statistics
The differences between baseline and exercise hemodynamic parameters were assessed
using paired-t tests. Because the cardiac output measured by the breath-by-breath Fick
technique (mCO) was highly variable (SD/mean = 35 ± 14%), measured and estimated
parameters corresponding to rest and submaximal exercise were averaged over two
minutes.
In Groups I and II, the effects of exercise on patient specific characteristic impedances,
Zc, were analyzed and when it was found to be negligible, the average Zc for each
patient, irrespective of the exercise stage was calculated using all beat-by-beat values.
This average Zc was then entered in Equation 1 to calculate beat-by-beat eCO values.
In Group III, an average Zc for each patient, irrespective of the posture and exercise
stage was calculated using data generated during the first exercise study at one month.
This average Zc was then utilized to calculate beat-by-beat eCO values for the data col-
lected at the four month exercise study using Equation 1.
A linear regression and Bland-Altman analyses were performed to assess the correla-
tion coefficient, the mean bias and the limits of agreement of the eCO compared to
mCO [21]. Finally, the tracking ability of the eCO to follow changes in mCO was
assessed by calculating the eCO and mCO changes from their respective baselines and
plotting these in a four quadrant and modified Bland-Altman plot along the lines
described by [22]. Analyses were performed using Axum (ver 4.0, Mathsoft, Cam-
bridge, MA). Data are expressed as the mean ± SD unless otherwise noted; p values
< 0.05 were considered statistically significant.
Results
Table 1 details the baseline characteristics of the study subjects. As a group, the
patients had a Fick derived cardiac output of 4.9 ± 1.4 L/min at a heart rate of 77 ±
14 beats/min at rest. The RV diastolic, estimated mean pulmonary artery pressure
and RV systolic pressures were above normal (RVDP: 13 ± 7 mmHg, eMPAP: 33 ± 12
mmHg, RVSP: 46 ± 19 mmHg) consistent with increased RV afterload. Both the
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-5) and oscillatory components of the RV afterload
(Zc: 48 ± 18 dyn.s.cm
-5, Γ: 0.86 ± 0.04) were elevated compared to normal [7].
A representative tracing of the heart rate, RV pressures and the RV afterload parameters
recoded during the exercise protocol is shown in Figure 2. Note that in this figure the
error bars show the variability of the data during each one minute period in this patient.
At sub-maximal exercise, both the pressures (RVDP: 22 ± 8 mmHg, eMPAP: 48 ±
10 mmHg, RVSP: 63 ± 15 mmHg) and the cardiac output (7.6 ± 2.5 L/min) were signifi-
cantly increased compared to rest. This increase in cardiac output during exercise was due
not only to an increased heart rate (77 ± 14 versus 101 ± 19 beats/min, p < 0.001) but also
to an increased stroke volume (from 66 ± 21 to 77 ± 27 ml, p < 0.001). There was a signif-
icant decrease in PAR of -91 ± 159 dyn.s.cm
-5 and a significant decrease in the coefficient
of wave reflection of -0.02 ± 0.04 units but no statistically significant change in Zc of 3 ±
9d y n . s . c m
-5 during exercise (Figure 3). Since the effects of exercise on patient specific
characteristic impedances, Zc, was found to be negligible, all beat-by-beat values of Zc
obtained during the exercise test were averaged to estimate a mean Zc for each patient.
This mean value was then used in Equation 1 to calculate beat-by-beat estimates of
cardiac output.
The eCO was similar to measured cardiac output, mCO, R
2 = 0.92, p < 0.001 (Figure 4,
A). The Bland-Altman analysis indicated a mean bias of the estimate of 0.1 L/min (4%).
The limits of agreement were -1.6 (-23%) to 1.7 L/min (30%) (Figure 4, B).
The trending ability of the algorithm using the four quadrant plot indicated that major-
ity of the data points were close to the line of identity of the four quadrant plot (Figure 5,
A). The trending effect was found to be significant (R
2 = 0.73). The corresponding modi-
fied Bland-Altman plot indicated a mean bias of the estimate of -0.6 L/min. The limits of
Table 1 The patient characteristics
Patient
No
Age
(years)
Body Surface Area
(m
2)
Cardiac Output* (L/
min)
NYHA
Class
LVEF
(%)
Aetiology
Group
I
1 71 1.75 5.9 III 35 Ischemic
2 67 2.42 4.1 III 17 Ischemic
3 67 1.83 3.6 III 17 Ischemic
4 60 1.75 3.3 III 20 Ischemic
5 76 1.66 3.3 III 23 Ischemic
6 79 1.81 4.8 II 40 Ischemic
Group
II
7 70 2.01 5.8 III 25 Ischemic
8 52 2.17 4.1 III 25 Ischemic
9 61 2.23 6.0 III 20 Ischemic
10 68 2.01 5.2 II 20 Ischemic
11 63 2.19 4.3 II 30 Ischemic
12 56 2.26 4.0 II 15 Ischemic
Group
III
13 53 2.60 7.5 II 15 Idiopathic
14 53 1.89 8.3 II 30 Ischemic
15 66 2.00 4.1 II 30 Ischemic
16 67 2.17 4.6 II 20 Ischemic
Mean ±
SD
64 ± 8 2.01 ± 0.26 4.9 ± 1.4 2.1 ± 0.5 24 ± 7
* cardiac output measured at supine rest using breath-by-breath Fick (Groups I and II) and direct Fick (Group III)
technique. NYHA = New York Heart Association, LVEF = Left Ventricular Ejection Fraction by echocardiography.
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relationship between the two methods.
Discussion
In this study, we used right ventricular pressure waveforms recorded with an
implanted hemodynamic monitor, to estimate the cardiac output at rest and during
bicycle exercise in patients with CHF. The results indicate that the PCCO algorithm
Figure 2 (Panel A) The minute-by-minute changes in hemodynamic parameters (HR = Heart Rate,
RVDP = Right ventricular end diastolic pressure, eMPAP = estimated mean pulmonary artery
pressure, RVSP = right ventricular systolic pressure, CO = Cardiac Output) and (Panel B) the right
ventricular afterload (Γ = coefficient of wave reflection, PAR = total pulmonary arterial resistance,
Zc= characteristic impedance) parameters during the exercise protocol in one patient. Bars
correspond to periods during which rest and submaximal exercise data were averaged. Data are shown as
mean and standard deviation for each one minute period.
Figure 3 The rest and submaximal exercise values of PAR = total pulmonary arterial resistance
(Left), Zc= characteristic impedance (Middle) and Γ= coefficient of wave reflection (Right) in all 16
patients. White circles = individual patients, black circles = group mean ± SD.
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are sufficient to provide estimates of the cardiac output at rest and during exercise.
Given the important role of cardiac output in the hemodynamic pathophysiology of
heart failure, continuous monitoring of this parameter over time using an implantable
device may be helpful to improve the long-term management of CHF patients.
Critchley and Critchley suggested that in order to accept a new cardiac output mea-
surement technique for clinical use, the limits of agreement should be within ± 30%
[23], The present technique provides a range of -3.0 to 1.9 L/min which is within this
recommended limit. In addition, serial measurements showed that changes in eCO
Figure 4 (Panel A) Linear regression plot and (Panel B) Bland-Altman plot depicting the agreement
between the measured and estimated cardiac outputs measured at rest and submaximal exercise.
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2 = 0.73) [22]. It has been shown that the
range of RV pressures monitored during daily living activities in patients with chronic
heart failure is larger compared with a standard limited exercise test [24]. However,
the conditions tested in our protocol likely represent the extremes of exertion and CO
response experienced in the daily life of patients with chronic heart failure.
In this study, steady and oscillatory RV afterload parameters were measured. The
results confirm that both the steady (the pulmonary arterial resistance, PAR), and
oscillatory (the characteristic impedance of the RV outflow tract, Zc, and the coefficient
Figure 5 The trend analysis using cardiac output change data from rest and exercise stages
presented in four quadrants trend (Panel A) and modified Bland-Altman (Panel B) plots along the
lines described by reference [22]. Line of identity and the regression coefficient are given in panel A.
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Page 9 of 13of wave reflection, Γ) components of the RV afterload were already elevated in these
patients with moderate HF [7]. The PCCO algorithm considers that the Zc of the RV
outflow tract essentially remains constant for a given individual [10,11]. In this study,
we found that during submaximal exercise the PAR decreased by ~17%, the amount of
wave reflection was reduced by ~3% but the Zc of the RV outflow tract remained
unchanged, confirming our initial hypothesis. Although the Zc appear to have quite
large increase with exercise in some patients, this observation was not consistent in all
patients (Figure 3, p = 0.16). This finding is consistent with earlier results, which sug-
gested that the Zc of the pulmonary artery remains nearly constant in various condi-
tions [7,25-27]. In the prospective arm of the study, we found that Zc again remained
constant over 3 months as neither the error nor the ability to track was compromised
(Figures 4 and 5). A theoretical study supported with empirical data is needed to better
understand this interesting observation.
The present investigation extends previous reports on the performance of the PCCO
algorithm from studies in acute open chest canines [10] and in humans with pulmon-
ary arterial hypertension [11] to chronic heart failure patients. In the first study, we
found that the PCCO algorithm provides good estimates of cardiac output during sys-
tematic preload, afterload and contractility changes [10]. In the second study, the
PCCO algorithm given by Equation 1 yielded cardiac output estimates that were highly
correlated with the breath-by-breath Fick cardiac output measurements during epo-
prostenol infusions in pulmonary hypertension patients [11].
The possibility for monitoring cardiac output has potential clinical implications in
assessing and managing CHF patients. Strategies to determine and control hemody-
namic status of patients with CHF in daily clinical practice commonly include regular
clinic visits for the assessment of volume status and filling pressures by physical exami-
nation or various types of non-invasive measurements. However, the typical physical
signs and symptoms of CHF have been shown to correlate poorly with measures of
central hemodynamics [25] and non-invasive methods can be difficult to access. More-
over, since repeated cardiac catheterizations for estimation of cardiac output and RV
afterload are associated with considerable risks, costs and inconvenience for the patient
these measurements are generally performed at one or more discrete points in time
without the disturbing influences of daily activities or stress.
To alleviate these shortcomings, an IHM which continuously records RV pressures
and heart rate has been developed. Although still an investigational device, the value of
IHM to predict deterioration in heart failure, preventing heart failure related hospitali-
zations and in tailoring drug treatment has been suggested in single and multicentre
studies [28,29] and has been evaluated in large multicentre settings [8,9]. These devel-
opments would be further improved if the RV pressure waveforms recorded by the
IHM could be utilized to estimate the cardiac output and the RV afterload. This infor-
mation could enhance the long-term assessment of hemodynamics and the guidance of
therapy in patients with heart failure without the need to perform invasive procedures.
However, the accuracy and reliability of the PCCO algorithm over time still needs to
be validated in a prospective study and the clinical usefulness of cardiac-output moni-
toring remains to be confirmed in clinical trials.
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This study is limited by its small sample size and the retrospective application of the
PCCO algorithm in a subset of the patients. The results obtained from the small group
of prospective patients in Group III reflect findings to a period of 12 weeks and might
require longer term studies for verification. Cardiac output was studied during supine
and upright stationary bicycle exercise which may not reflect ambulatory conditions in
patients performing daily living activities.
We considered that the level of error that the PCCO algorithm introduces is accep-
table if one uses breath-by-breath or direct Fick method as the reference. It is possible
that the PCCO algorithm might not be acceptable if a different reference, such as ther-
modilution, were to be used. In this study, we employed these Fick methods as refer-
ence because in the presence of tricuspid regurgitation, a potential when cathethers are
introduced in the RV, the Fick reference was found to be superior to thermodilution
[30].
It cannot be ruled out that the observed increase in cardiac output might also be due
to reduced left ventricular afterload and improved left ventricular filling. Since in this
study pulmonary arterial resistance, the steady component of RV afterload [6], was cal-
culated any changes in LV filling pressures might confound our results.
In this study, we did not report and analyze the effect of some of the other hemody-
namic parameters (pulmonary vascular resistance in Wood’s Units, the resting and
exercise blood pressures, etc.) and the medications (diuretics, ace inhibitors, beta
blockers, etc.) on these findings. Further systematic studies with larger sample sizes are
needed to address the influence of such parameters on these findings.
Conclusions
In this study of patients with chronic heart failure, the RV pressure waveform recorded
by an implantable hemodynamic monitor accurately and repeatedly measured cardiac
output at rest and during exercise in an acute setting. This information, together with
the corresponding data on cardiac filling pressures derived from the RV pressure sen-
sor, could be useful in the long-term assessment of hemodynamic status and therapy
response in heart failure patients.
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